SAN DIEGO, Dec. 6, 2011 /PRNewswire/ -- BioSurplus announced today that it will be hosting two major online lab equipment auctions beginning on January 5th and 26th, consecutively.
The auctions feature high-quality used equipment from working labs, including Agilent 1100 HPLCs, a Micromass ZQ Mass spec with a Waters 2795 HPLC system, a Tecan Freedom Evo liquid handler, a Nikon TE 300 Inverted Research Microscope and many more.
The January 5th auction includes a variety of equipment from internationally renowned biotech firms. Among them are Acadia Pharmaceuticals, Isis Pharmaceuticals and leading DNA sequencing technology powerhouse Illumina, Inc.
The January 26th auction is made up of surplus equipment from Elan Pharmaceuticals' facilities in South San Francisco, California.
Information about the lots in each auction, including equipment descriptions and photos, are available for viewing at http://auctions.biosurplus.com. There will be over 300 lots in the January 5th auction, and over 550 in the Elan auction; lots will continue to be added as the dates approach, so it's recommended that all participants check back often for new additions.
Since 2002, BioSurplus has assembled a team of scientific experts to pioneer leading edge solutions for every stage of the lab equipment lifecycle. From providing a website of dynamic inventory, as well as live and online auctions, to developing software solutions that allows clients to manage their own equipment, to offering turnkey solutions for selling surplus assets, BioSurplus is dedicated to maximizing the value and use of laboratory equipment for its customers. To this end, it has become a leading supplier of pre-owned laboratory instruments and equipment management services.
BioSurplus is headquartered in San Diego and has large showrooms in San Diego and the San Francisco Bay Area, and a new showroom in Korea. BioSurplus offers services nationally and sells equipment worldwide. For more information, please visit the corporate website at www.BioSurplus.com.
Copyright©2010 PR Newswire.
All rights reserved